This service uses attributes from Fine Needle Aspirates to determine if a breast mass is malignant or benign. The current network is 99.11% sensitive to malignancy and 7.6 million trials demonstrated the service will improve as more samples are collected from the worldwide hospital community. If you would like to contribute samples, please contact Brittany Wenger at [email protected].

Recently awarded Google Science Fair Grand Prize Winner! Visit the project site for more information.